EP12.01-26 Aumolertinib as Neoadjuvant and Adjuvant Therapy for Unresectable Stage IIIA-IVA Non-Small Cell Lung Cancer with EGFR Mutations
Fei Shao(Nanjing Chest Hospital), Shu Fang(Peking University), Nan Liu(Nanfang Hospital), Hui Fang(Wuhan University), Wenwu Cheng(Nanjing Chest Hospital), Qiang Zhang(East China Normal University)
Cited by 0
Related Papers
Adaptive genic evolution in the <i>Drosophila</i> genomes
|Proceedings of the National Academy of Sciences|2007|227
Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance
|British Journal of Cancer|2019|202
A smart aminoglycoside hydrogel with tunable gel degradation, on-demand drug release, and high antibacterial activity
|Journal of Controlled Release|2017|195